(BBIO) BridgeBio Pharma - Performance 67% in 12m
BBIO performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
21.58%
#15 in Peer-Group
Rel. Strength
90.30%
#748 in Stock-Universe
Total Return 12m
66.99%
#19 in Peer-Group
Total Return 5y
47.31%
#21 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 47.69 USD |
| 52 Week Low | 22.35 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 87.77 |
| Buy/Sell Signal +-5 | -0.90 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: BBIO (67%) vs XBI (-11.7%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
0.74% | 53.2% | 70.2% | 24.1 | 14.3 | 0.24 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
3.64% | -10.3% | 158% | 12 | 11 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
2.83% | -8.28% | 33.6% | 27.4 | 14.2 | 0.99 | 0.60% | 41% |
| NBIX NASDAQ Neurocrine Biosciences |
7.39% | -7.29% | 0.13% | 45.7 | 26.2 | 0.27 | 18.7% | -34.3% |
| BIM PA Biomerieux |
-1% | 26.9% | -7.57% | 32.7 | 25.8 | 1.55 | -38.5% | -25.1% |
| KMDA NASDAQ Kamada |
4.06% | 31.3% | -17.2% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-4.56% | 41.9% | -8.93% | 7.54 | 6.09 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
- | 27% | 13.6% | 28.8 | 15.2 | 0.63 | -62.1% | -19.3% |
Performance Comparison: BBIO vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for BBIO
| Total Return (including Dividends) | BBIO | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 16.65% | 7.34% | 5.42% |
| 3 Months | 38.00% | 16.06% | 19.66% |
| 12 Months | 66.99% | -11.67% | 14.17% |
| 5 Years | 47.31% | -26.49% | 107.98% |
| Trend Stabilty (consistency of price movement) | BBIO | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 81.9% | 88.2% | 91.9% |
| 3 Months | 78.1% | 79.7% | 97.6% |
| 12 Months | 85.1% | -86.7% | 47.9% |
| 5 Years | -23.9% | -51.5% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th68.50 | 8.67% | 10.65% |
| 3 Month | %th69.00 | 18.90% | 15.32% |
| 12 Month | %th90.50 | 89.06% | 46.26% |
| 5 Years | %th90.50 | 100.40% | -29.17% |
FAQs
Does BridgeBio Pharma (BBIO) outperform the market?
Yes,
over the last 12 months BBIO made 66.99%, while its related Sector, the SPDR S&P Biotech (XBI) made -11.67%.
Over the last 3 months BBIO made 38.00%, while XBI made 16.06%.
Performance Comparison BBIO vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
BBIO vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 0.7% | 11.2% | 32.6% | 53% |
| US NASDAQ 100 | QQQ | -0.1% | 10.4% | 30.4% | 50% |
| German DAX 40 | DAX | 1.4% | 12.7% | 22.2% | 36% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 0.2% | 10.5% | 28.8% | 48% |
| Hongkong Hang Seng | HSI | -0.6% | 12.2% | 12.1% | 32% |
| India NIFTY 50 | INDA | 1.5% | 14.5% | 30.8% | 70% |
| Brasil Bovespa | EWZ | 1.1% | 18.1% | 18.6% | 65% |
BBIO vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 1% | 13.3% | 28.2% | 41% |
| Consumer Discretionary | XLY | 1.5% | 11.7% | 41.8% | 51% |
| Consumer Staples | XLP | 1% | 15.2% | 32% | 61% |
| Energy | XLE | 3.4% | 18.1% | 44.6% | 71% |
| Financial | XLF | 1.4% | 11.8% | 33% | 45% |
| Health Care | XLV | 3.7% | 16.7% | 42.8% | 77% |
| Industrial | XLI | 0.3% | 9.8% | 27.5% | 45% |
| Materials | XLB | 3.5% | 13% | 35.4% | 67% |
| Real Estate | XLRE | 0.8% | 15.8% | 35.2% | 62% |
| Technology | XLK | -0.6% | 8.3% | 26.4% | 50% |
| Utilities | XLU | 1.3% | 13.4% | 32.4% | 46% |
| Aerospace & Defense | XAR | -5.3% | 3.8% | 9% | 15% |
| Biotech | XBI | 1.3% | 9.3% | 38.1% | 79% |
| Homebuilder | XHB | 4.5% | 6.5% | 45.4% | 75% |
| Retail | XRT | 2.8% | 12.1% | 36.4% | 64% |
BBIO vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 0% | 24.1% | 46.0% | 73% |
| Natural Gas | UNG | -5.4% | 27.3% | 52.7% | 53% |
| Gold | GLD | 0.6% | 18% | 14.9% | 32% |
| Silver | SLV | -1.7% | 14% | 12.8% | 42% |
| Copper | CPER | 2.9% | 2.7% | 13% | 42% |
BBIO vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 3.2% | 17.9% | 38.6% | 73% |
| iShares High Yield Corp. Bond | HYG | 1% | 15.3% | 34.5% | 58% |